Cisplatin/Paclitaxel/Gemcitabine +/- Avastin in Patients With Unknown Primary Tumor

Sponsor: Rigshospitalet, Denmark
Study ID: NCT00458315
Phase: PHASE2
Status: Withdrawn

Conditions

Unknown Primary Tumors

Eligibility Criteria

Sex: ALL
Age: 18 Years - 70 Years
Healthy Volunteers: Not accepted

Interventions

Cisplatin — DRUG
Paclitaxel — DRUG
Gemcitabine — DRUG
Avastin (Bevacizumab) — DRUG

Study Details

The purpose of this study is to investigate the efficacy of Cisplatin, Paclitaxel, Gemcitabine +/- Avastin (Bevacizumab) in patients with unknown primary tumors.

Key Dates

First listed: Apr 10, 2007
Start date: May 31, 2007
Status verified: Sep 2009
Primary completion: Aug 31, 2007
Completion: May 31, 2012

Study Design

Enrollment: 0 participants (actual)
Allocation: RANDOMIZED
Intervention model: PARALLEL
Primary purpose: TREATMENT

Primary Outcome Measure

Progression Free Survival